| 昂丹司琼对肺癌化疗所致恶心呕吐的预防 |
| |
| 引用本文： | 邱栋发,黄窕姮,张招莲. 昂丹司琼对肺癌化疗所致恶心呕吐的预防[J]. 医药导报, 2001, 20(3): 180-181 |
| |
| 作者姓名： | 邱栋发 黄窕姮 张招莲 |
| |
| 作者单位： | 福建省三明市第一医院呼吸内科, |
| |
| 摘 要： | 目的：评价单剂昂丹司琼对肺癌化疗所致恶心、呕吐的预防作用。方法：选择35例肺癌化疗患者，采用自身交替对照的方法，观察单次静脉注射昂丹司琼8mg对化疗所致恶心、呕吐的预防作用。结果：单剂昂丹司琼对肺癌化疗所致恶心、呕吐的控制率分别为91．4％、94．3％；甲氧氯普胺的控制率分别为65．7％，74．3％，两者比较差异显著。结论：单剂昂丹司琼对肺癌化疗所致恶心、呕吐有明显的预防作用。
|
| 关 键 词： | 昂丹司琼 甲氯氯普胺 肺癌 呕吐 药物疗法 化疗 预防 |
| 文章编号： | 1004-0781(2001)03-0180-02 |
| 修稿时间： | 2000-02-23 |
The Effect of Ondansetronin Prevention of Chemotherapy-induced Nausea and Vomitus in Lung Cancer Patients |
| |
| QIU Dong-fa,HUANG Tiao-heng,ZHANG Zhao-lian. The Effect of Ondansetronin Prevention of Chemotherapy-induced Nausea and Vomitus in Lung Cancer Patients[J]. Herald of Medicine, 2001, 20(3): 180-181 |
| |
| Authors: | QIU Dong-fa HUANG Tiao-heng ZHANG Zhao-lian |
| |
| Abstract: | Objective:To evaluate the effect of single-dose ondansetron in prevention of chemotherapy-induced nausea and vomitus in lung cancer patients. Methods:35 lung cancer patients receiving chemotherapy were observed with self-comparisonal design. A single dose of 8mg ondansetron and of 20mg metoclopramide were administered by intravenous injection and intramuscular in jection to the patients at different time and the outcome was observed. Results:The control rates of nausea and vomitus by ondansetron were 91.4% and 94.3%, and 65.7% and 74.3% by metoclopramide respectively(P<0.05). Conclusion:A single-dose of ondansetron can effectively prevent nausea and vomitus in lung cancer patients caused by chemotherapy. |
| |
| Keywords: | Ondansetron Metoclopramide Lung cancer Chemotherapy Vomitus |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
